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A common NYX mutation in Flemish patients with X-linked
CSNB
Abstract
Aims: The Schubert-Bornschein type of complete congenital stationary night blindness (CSNB) is a
genetically heterogeneous retinal disorder. It is characterized by a non-progressive disease course, often
associated with high myopia and nystagmus. So far mutations in two genes, NYX (nyctalopin) and
GRM6 (metabotropic glutamate receptor 6) have been associated with this form of CSNB. The purpose
of this study was to identify the genetic defect in affected male patients from Flemish families with
complete CSNB. Methods: Probands with CSNB from 3 large Flemish families underwent
ophthalmologic examination. DNA was extracted from peripheral blood and the coding region of NYX
along with parts of the 5;UTR and 3;UTR and intronic regions covering the splice sites were PCR
amplified and sequenced. Results: In the affected individuals of 3 Flemish families with the complete
form of CSNB a novel NYX mutation, c.855delG was identified. This deletion is predicted to lead to a
frameshift mutation, p.Asp286ThrfsX62 causing a premature stop codon. Conclusion: Previously, both
single families with different mutations in NYX as well as different families with an identical mutation,
suggestive of a founder mutation, have been described. The c.855delG deletion in NYX seems to be a
common mutation associated with CSNB in the Flemish population from Belgium. Thus we suggest
performing diagnostic testing for CSNB in the Flemish population initially directed towards the
identification of this mutation. Subsequent screening for other mutations in NYX or GRM6 could be
performed as a second step.
doi:10.1136/bjo.2008.143727 
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ABSTRACT 
 
Aims: The Schubert-Bornschein type of complete congenital stationary night 
blindness (CSNB) is a genetically heterogeneous retinal disorder. It is characterized 
by a non-progressive disease course, often associated with high myopia and 
nystagmus. So far mutations in two genes, NYX (nyctalopin) and GRM6 
(metabotropic glutamate receptor 6) have been associated with this form of CSNB. 
The purpose of this study was to identify the genetic defect in affected male patients 
from Flemish families with complete CSNB. 
Methods: Probands with CSNB from 3 large Flemish families underwent 
ophthalmologic examination. DNA was extracted from peripheral blood and the 
coding region of NYX along with parts of the 5`UTR and 3`UTR and intronic regions 
covering the splice sites were PCR amplified and sequenced. 
Results: In the affected individuals of 3 Flemish families with the complete form of 
CSNB a novel NYX mutation, c.855delG was identified. This deletion is predicted to 
lead to a frameshift mutation, p.Asp286ThrfsX62 causing a premature stop codon.  
Conclusion: Previously, both single families with different mutations in NYX as well 
as different families with an identical mutation, suggestive of a founder mutation, 
have been described. The c.855delG deletion in NYX seems to be a common mutation 
associated with CSNB in the Flemish population from Belgium. Thus we suggest 
performing diagnostic testing for CSNB in the Flemish population initially directed 
towards the identification of this mutation. Subsequent screening for other mutations 
in NYX or GRM6 could be performed as a second step.  
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INTRODUCTION 
The Schubert-Bornschein type of CSNB 1is characterized by a distinctly shaped dark-
adapted combined rod-cone electroretinogram (ERG) to a single bright white flash: 
the amplitude of the a-wave is normal and larger than that of the b-wave, leading to its 
electronegative aspect. Under psychophysical dark adaptation, rod adaptation is 
dramatically reduced or completely absent and cone adaptation may show variable 
threshold elevations in most patients 2-4. Miyake and co-workers further divided this 
type of CSNB into two subtypes, incomplete and complete 5. The incomplete form of 
CSNB is characterized by a reduced rod b-wave as well as a substantially reduced 
cone response, while the complete type of CSNB is associated with either absent or 
very low amplitudes of the rod b-wave response and normal cone amplitudes. Both 
types can be inherited as an X-linked (XL-CSNB) or autosomal recessive (ar) trait. 
Mutations in CACNA1F (Xp11.23) and CABP4 (11q13.1) lead to the incomplete 
form, whilst mutations in NYX (Xp11.4) and GRM6 (5q35) are associated with the 
complete form of CSNB 6-13. 
To date, the majority of mutations have been identified in two X-linked genes, 
CACNA1F and NYX, which are assumed to play a role downstream of the 
phototransduction cascade in transmitting the signal from the photoreceptors to the 
adjacent bipolar cells 14.  
NYX comprises 3 exons, and codes for a protein, nyctalopin, which belongs to the 
small leucine rich proteoglycan family. Although immunofluorescence and Western 
blot analyses have shown that the protein is attached to the cell surface via a GPI 
anchor 15;16, and plays a role in transmitting the biochemical signal from the 
photoreceptors to the adjacent bipolar cells, the exact role of this protein still has to be 
discovered 14. Up to now, 37 different mutations in NYX have been associated with the 
complete type of CSNB 14. From this total of 37 mutations, 24 single families have 
been associated with a different mutation. The remaining 13 mutations represent 
different recurring mutations, most notably a 24 bp deletion, p.Arg29_Ala36del, 
identified in 7 families originating from the USA with a common founder 13. 
The objective of this study was to identify the disease causing mutation in three 
apparently unrelated large Flemish families with complete CSNB. 
 
 
MATERIALS AND METHODS 
Patients 
Informed consent was obtained from the participants, in accordance with guidelines 
established by the Declaration of Helsinki. 
 
Clinical Assessments of Patients  
All affected members of the three families underwent an extensive ophthalmological 
evaluation, including Snellen visual acuity testing, slit lamp biomicroscopy, 
fundoscopy, Goldmann visual fields, colour vision examination, ISCEV-standard 
electroretinography and on-off responses (total flash duration of 200 milliseconds), 
and infrared, autofluorescence and red free imaging. Blood was taken from all family 
members by venesection and genomic DNA extracted according to accepted 
procedures (Puregene, Gentra, Inc, Minneapolis, USA). 
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Mutation Analysis 
Four PCR fragments containing the exons 1-3 of NYX were amplified with primers 
previously described 17, by using DNA polymerase (HotFirePoly, Soli Biodyne, Tartu, 
Estonia), 1.5 mM MgCl2 (Exon 1 – 2, fragments B and C of exon 3) or 2.5 mM 
MgCl2 (fragment B of exon 3) and an annealing temperature of 56°C (exons 1 - 2) or 
58°C (all fragments of exon 3) in the presence of Q-solution (Qiagen, 
Hombrechtikon, Switzerland). Purification and sequencing was performed with the 
appropriate primers as described earlier 10. The DNA of 43 Flemish females and 51 
Flemish unaffected males served as controls for this study. 
Genotyping 
Four polymorphic microsatellite markers were used for genotyping the affected 
individuals of families A, B, and C (Figure 1). Products of PCR assays with 
fluorescently labeled primers were analyzed by automated capillary genotyping on an 
ABI 3730 DNA Analyser (Applied Biosystems) and scored using the GeneMapper® 
analysis software (Applied Biosystems). 
 
 
RESULTS AND DISCUSSION 
All seven affected family members of the three Flemish families have been diagnosed 
with complete CSNB (Figure 1). The diagnosis was based on a combination of 
congenital night blindness without photophobia, subnormal best-corrected visual 
acuity with nystagmus but (near-) normal visual fields, a documented personal or 
family history of stationary disease, fundus changes limited to myopia with macular 
hypoplasia, absence of hyperautofluorescence on autofluorescence imaging (Figure 
2), and Schubert-Bornschein complete type ERG abnormalities (Figures 2 and 3 and 
Supplementary Table 1). All patients are males, have a family history compatible with 
X-linked inheritance and the three families are apparently unrelated (Figure 1). They 
all had been diagnosed in their first few years of life, after failing to fix and follow at 
the age of 3 months, in the presence of nystagmus. Normal fundus autofluorescence 
imaging, which was performed in six patients, further supported the stationary nature 
of the disease. 
The DNAs from seven male patients from the three different families were screened 
for mutations in the NYX gene. In all of them a c.855delG was identified (Figure 4). 
Additionally, also the carrier status of 4 unaffected females of theses families have 
been investigated (A-IV3, A-IV10, B-IV7 C-IV7) (Figure 1). Only B-IV7 did not carry 
the mutation. These studies clearly showed that the mutation c.855delG co-segregates 
within these families. None of the 137 control alleles from the same population 
revealed this mutation. The deletion is predicted to lead to a shift in the open reading 
frame, p.Asp286ThrfsX62, and causes a premature stop codon. Microsatellite 
screening of markers near the NYX locus revealed that all affected individuals of the 
three Flemish families share the same haplotype in the 6.1 cM region limited by the 
markers DXS993 and DXS8035 (see table 1). The haplotypes of a close located 
marker DXS1068 at position 60.25 cM is distinct in the different families but also 
within the same family, indicating that recombination occurred (data not shown). 
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Table 1 Haplotype analysis of the patients with the c.855delG mutation in NYX. 
 
 
 
 
                                            Alleles of patients 
Marker Position cM  AIII14 AV1 AIV4 BIV6 CV1 CV3 CV4 
DXS993 63.90  307 307 307 307 307 307 307 
NYX  [c.855delG] [c.855delG] [c.855delG] [c.855delG] [c.855delG] [c.855delG] [c.855delG] 
DXS6810 66.88  222 222 222 222 222 222 222 
DXS8035 70.00  138 138 138 138 138 138 138 
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These studies suggest that a common founder mutation of NYX is associated with the 
complete form of CSNB in the Flemish population of Belgium. Consequently, 
molecular testing in Flemish patients with a suspected diagnosis of complete CSNB 
should be directed first towards identification of this common mutation by sequencing 
only the respective part of exon 3 of NYX. After exclusion of this common mutation, 
screening for other mutations in either NYX or GRM6 can be performed as a second 
step.  
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APPENDIX 
 
Figure legends 
 
Figure 1: 
 
Pedigrees of patients showing a c.855delG mutation in the NYX gene, which is 
predicted to lead to a frameshift mutation, p.Asp286ThrfsX62. Males are represented 
by boxes, females by circles. Filled boxes indicate that the patient is affected; dots 
indicate a carrier status; “wt” means “wild type”; arrows indicate patients examined. 
 
Figure 2: 
 
A/ Composite fundus image of right eye of individual IV6 of Family B: note tilted 
optic disc with temporal peripapillary chorioretinal atrophy and macular hypoplasia 
with increased visibility of the choroidal vasculature 
B/ On-Off responses of three affected individuals as indicated on left (LE = left eye, 
RE = right eye); representative normal control at bottom for purposes of comparison; 
note absence of on-response in all patients, with preservation of off-response 
C/ Composite infrared image of fundus of left eye of individual III14 of Family A: 
note tilted disc, pronounced peripapillary atrophy and macular hypoplasia 
D/ Autofluorescence image of fundus of right eye of individual III14 of Family A: 
background autofluorescence is normal 
 
 
Figure 3: 
 
ISCEV standard full-field flash electroretinography (ERG) of 4 representative CSNB 
patients (LE = left eye, RE = right eye) as indicated on left, and representative normal 
control at bottom: note typical Schubert-Bornschein complete type abnormalities 
with: absent or residual rod-specific responses, electronegative mixed rod-cone 
responses; absent scotopic oscillatory potentials, cone-specific responses to transient 
flash with normal amplitudes but broadened a-wave due to loss of photopic oscillatory 
potentials (slight delay in individual III14 of Family A), and (near-) normal cone-
responses to 30Hz flickering stimulus 
 
 
Figure 4: 
 
Electropherogram showing the hemizygous c.855delG mutation in a male patient and 
the heterozygous carrier state in the patient’s mother, compared to a control. 
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